Phase 2 Uveal Melanoma Clinical Trials
14 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–14 of 14 trials
Recruiting
Phase 2
Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
Mestastatic Uveal Melanoma
Grupo Español Multidisciplinar de Melanoma19 enrolled4 locationsNCT07057596
Recruiting
Phase 2
Neoadjuvant Tebentafusp for Uveal Melanoma
Locally Advanced Unresectable Uveal Melanoma
Thomas Jefferson University19 enrolled2 locationsNCT06414590
Recruiting
Phase 2
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Uveal Melanoma
Diwakar Davar44 enrolled3 locationsNCT06070012
Recruiting
Phase 2
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
Metastatic Uveal MelanomaMetastatic Uveal Melanoma in the Liver
University of Miami30 enrolled1 locationNCT06627244
Recruiting
Phase 2Phase 3
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
Replimune Inc.280 enrolled31 locationsNCT06581406
Recruiting
Phase 1Phase 2
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Colorectal, CancerCutaneous MelanomaOther Solid Tumors+1 more
IDEAYA Biosciences336 enrolled15 locationsNCT03947385
Recruiting
Phase 2
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
Uveal MelanomaOcular Melanoma
H. Lee Moffitt Cancer Center and Research Institute37 enrolled1 locationNCT05524935
Recruiting
Phase 2
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute32 enrolled4 locationsNCT06121180
Recruiting
Phase 2
Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute18 enrolled1 locationNCT07276386
Recruiting
Phase 1Phase 2
Tebentafusp-tebn With LDT in Metastatic UM
Metastatic Uveal Melanoma
Thomas Jefferson University109 enrolled1 locationNCT06626516
Recruiting
Phase 1Phase 2
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Metastatic Uveal MelanomaUveal Melanoma, MetastaticUveal Melanoma, Recurrent+2 more
Novelwise Pharmaceutical Corporation36 enrolled3 locationsNCT07136181
Recruiting
Phase 1Phase 2
Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
Uveal MelanomaMetastatic Uveal MelanomaMetastatic Uveal Melanoma in the Liver
St Vincent's Hospital, Sydney8 enrolled2 locationsNCT07063875
Recruiting
Phase 2
Adjuvant Quisinostat in High-Risk Uveal Melanoma
Uveal Melanoma
University of Miami63 enrolled1 locationNCT06932757
Recruiting
Phase 2
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
Uveal Melanoma
California Pacific Medical Center Research Institute40 enrolled1 locationNCT05077280